Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).
NCT ID: NCT06952127
Last Updated: 2025-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2023-04-07
2024-03-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Are the study procedures feasible?
* Will the two groups have similar results for the preliminary efficacy outcomes?
Researchers will compare group telerehabilitation to a face-to-face group to see if it's comparable.
Participants will:
* Take part in a 60-minute training session, 3 times a week in person or remotely
* Visit the clinic before starting the training program and after 8 weeks of training
* Keep a diary of their symptoms, if any
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telerehabilitation group
Rehabilitation program including cardiovascular, muscular and balance training and, if necessary, respiratory physiotherapy using the Teams platform supervised by a certified kinesiologist. The rehabilitation will be conducted 3 times a week for 8 weeks in group of 5 or 6 persons.
Rehabilitation program
* 5-minute warm-up including easy global exercises
* 5 resistance training exercises targeting upper and lower muscle groups
* 30 secondes break between sets
* Cooldown with breathing and stretching exercises
Face-to-face group
Rehabilitation program including cardiovascular, muscular and balance training and, if necessary, respiratory physiotherapy at the university kinesiology clinic supervised by a certified kinesiologist. The rehabilitation will be conducted 3 times a week for 8 weeks in group of 5 or 6 persons.
Rehabilitation program
* 5-minute warm-up including easy global exercises
* 5 resistance training exercises targeting upper and lower muscle groups
* 30 secondes break between sets
* Cooldown with breathing and stretching exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rehabilitation program
* 5-minute warm-up including easy global exercises
* 5 resistance training exercises targeting upper and lower muscle groups
* 30 secondes break between sets
* Cooldown with breathing and stretching exercises
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* confirmed SARS-CoV-2 infection defined by positive polymerase chain reaction (PCR) testing and/or antigen test results
* referred to the pneumology clinic for a modified British Medical Research Council (mMRC) dyspnea score of 2-3 after a minimum of eight weeks of infection
* VO₂max of less than 80% of the predicted value
* receiving a medical prescription for rehabilitation following initial assessment by a pulmonologist
* being able to walk independently
* providing informed consent
* having a good internet connection (i.e., a minimum download speed of 4 Mbps and an upload speed of 4 Mbps)
* being in possession of a computer or tablet equipped with a camera enabling videoconferencing.
Exclusion Criteria
* evidence of medical instability (i.e., moderate or severe cardiac disease, ischemic or severe hemorrhagic stroke, or neurodegenerative disease, unstable fracture)
* history of severe cognitive or mental impairment
* already enrolled in another rehabilitation program
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marie-Claude Lehoux
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre hospitalier affilié universitaire régional
Trois-Rivières, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
889
Identifier Type: REGISTRY
Identifier Source: secondary_id
2023-667
Identifier Type: -
Identifier Source: org_study_id